New Toolkit Helps Clinicians Combine Lifestyle Interventions with Obesity Medications

Key takeaways:

• The American College of Lifestyle Medicine launched a toolkit to assist clinicians pair weight problems drugs with structured life-style interventions.
• Without life-style integration, sufferers utilizing weight problems drugs face elevated dangers comparable to nutrient deficiency, lack of lean mass, and weight regain.
• The toolkit affords clinician steering and patient-facing schooling spanning remedy initiation, titration, upkeep, and potential discontinuation.
• It is obtainable at no cost to ACLM members and for $49 to non-members.

As using weight problems drugs like GLP-1 receptor agonists expands, the American College of Lifestyle Medicine (ACLM) has launched a brand new Obesity Medications & Lifestyle Medicine Toolkit to help clinicians in delivering safer and extra sustainable weight problems care.

With one in eight adults reporting present use of weight problems drugs and one in 5 having used them sooner or later, these therapies are altering the weight problems care panorama. Clinical trials establishing the efficacy of those drugs paired pharmacotherapy with structured life-style interventions, comparable to dietary counseling and bodily exercise targets.

Without structured life-style medication integration, sufferers face larger dangers of gastrointestinal unwanted side effects, insufficient nutrient consumption, lack of lean mass and bone density, practical decline, psychological misery, and weight regain. However, there has beforehand been a scarcity of particular info relating to using life-style interventions as adjunctive remedy.

“Obesity medications can be powerful tools, but they are not stand-alone solutions,” says Kate Cohen, MS, RD, CDN, DipACLM, medical nutritionist at Hospital for Special Surgery, who helped develop the toolkit, in a launch. “We’re in a time of unprecedented adoption of these new medications, but up until now, we have been lacking straightforward, practical guidance on how to pair these therapies with evidence-based lifestyle care. I’m excited that this toolkit provides much-needed support for clinicians and patients and the challenges they are facing right now.”

The toolkit supplies sensible, clinician-ready steering and a library of patient-facing schooling throughout the complete course of weight problems remedy use—from initiation and titration to upkeep and potential discontinuation.

Key options embrace:

• Expert medical summaries on integrating weight problems drugs with the six pillars of life-style medication: optimum diet, bodily exercise, restorative sleep, stress administration, connectedness, and avoidance of dangerous substances
• Clear steering on danger mitigation, together with defending muscle mass, dietary adequacy, hydration, and psychological well being in periods of lowered urge for food and fast weight change
• Language and framing instruments to assist respectful, individual‑first conversations that enhance belief, adherence, and shared choice‑making
• Symptom‑administration methods to scale back gastrointestinal unwanted side effects and forestall pointless remedy discontinuation
• Behavioral screening and referral pathways to assist clinicians determine when extra diet, behavioral well being, or specialty assist is required
• Downloadable affected person handouts that translate medical steering into actionable, supportive schooling for sufferers utilizing weight problems drugs

ACLM developed the toolkit in response to rising considerations amongst clinicians about how weight problems drugs are being utilized in real-world settings, usually with out enough life-style counseling. It is designed to be used throughout main care, endocrinology, cardiology, weight problems medication, and different medical settings the place weight problems is handled.

“The toolkit reinforces ACLM’s position that the primary goal of obesity treatment is improved health, function, and quality of life—not simply weight loss,” says Jasdeep Saluja, MD, FRCPC, DipABLM, DipABOM, chief medical officer at Aroga Lifestyle Medicine and chair of ACLM’s GLP-1 Committee, in a launch. “With these resources, clinicians can align rapidly evolving obesity treatments with current evidence, professional guidelines, and whole-person care.”

The Obesity Medications & Lifestyle Medicine Toolkit is obtainable free to ACLM members and for $49 to non-members.

Read More on GLP-1s: